Rovi has gained FDA approval for its drug Risvan to treat schizophrenia in adults. The approval led to a nearly 3% surge in Rovi's stock. Risvan,...
Ipsen markets more than twenty medicines in more than 115 countries and has a direct commercial presence in more than 30 states. Ipsen's research and development...